Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Picchio

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Medical Virology|May 23, 1998
HTLV-Is in Argentina are phylogenetically similar to those of other South American countries, but different from HTLV-Is in AfricaM Yamashita, G Picchio, R Veronesi, et al.
Journal of Virological Methods|June 19, 2007
Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modelingH Vermeiren, E Van Craenenbroeck, P Alen, et al.
Zeitschrift Fur Gastroenterologie|January 15, 2005
Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assayH L Tillmann, J Wiegand, I Glomb, et al.
Journal of Viral Hepatitis|June 26, 2003
Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapyM Maynard, P Pradat, P Berthillon, et al.
Leukemia Research|October 1, 1992
Transfer of human chronic lymphocytic leukemia to mice with severe combined immune deficiencyR Kobayashi, G Picchio, M Kirven, et al.
Journal of Viral Hepatitis|November 18, 2014
Incidence of virological failure and emergence of resistance with twice-daily vs every 8-h administration of telaprevir in the OPTIMIZE studyI Dierynck, A Ghys, J Witek, et al.
Cancer Research|September 1, 1992
Cytogenetic characterization of B-cell lymphomas from severe combined immunodeficiency disease mice given injections of lymphocytes from Epstein-Barr virus-positive donorsM Thangavelu, L Snyder, J Anastasi, et al.
Journal of Viral Hepatitis|May 8, 2013
Analysis of genotype 2 and 3 hepatitis C virus variants in patients treated with telaprevir demonstrates a consistent resistance profile across genotypesS De Meyer, A Ghys, G R Foster, et al.
Viral Immunology|January 1, 1997
Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell linesR Rochford, M J Cannon, R E Sabbe, et al.
Medicina|January 1, 1990
Suppression of T cell proliferation induced by concanavalin A in hemophilia patientsM C Sasiain, S de la Barrera, B Ruibal Ares, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Medical Virology|May 23, 1998
HTLV-Is in Argentina are phylogenetically similar to those of other South American countries, but different from HTLV-Is in AfricaM Yamashita, G Picchio, R Veronesi, et al.
Journal of Virological Methods|June 19, 2007
Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modelingH Vermeiren, E Van Craenenbroeck, P Alen, et al.
Zeitschrift Fur Gastroenterologie|January 15, 2005
Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assayH L Tillmann, J Wiegand, I Glomb, et al.
Journal of Viral Hepatitis|June 26, 2003
Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapyM Maynard, P Pradat, P Berthillon, et al.
Leukemia Research|October 1, 1992
Transfer of human chronic lymphocytic leukemia to mice with severe combined immune deficiencyR Kobayashi, G Picchio, M Kirven, et al.
Journal of Viral Hepatitis|November 18, 2014
Incidence of virological failure and emergence of resistance with twice-daily vs every 8-h administration of telaprevir in the OPTIMIZE studyI Dierynck, A Ghys, J Witek, et al.
Cancer Research|September 1, 1992
Cytogenetic characterization of B-cell lymphomas from severe combined immunodeficiency disease mice given injections of lymphocytes from Epstein-Barr virus-positive donorsM Thangavelu, L Snyder, J Anastasi, et al.
Journal of Viral Hepatitis|May 8, 2013
Analysis of genotype 2 and 3 hepatitis C virus variants in patients treated with telaprevir demonstrates a consistent resistance profile across genotypesS De Meyer, A Ghys, G R Foster, et al.
Viral Immunology|January 1, 1997
Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell linesR Rochford, M J Cannon, R E Sabbe, et al.
Medicina|January 1, 1990
Suppression of T cell proliferation induced by concanavalin A in hemophilia patientsM C Sasiain, S de la Barrera, B Ruibal Ares, et al.
Pageof 2